This Obesity Drug Cuts Calorie Intake by 72% Without Dieting

This Obesity Drug Cuts Calorie Intake by 72% Without Dieting

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for hunger and reward in patients treated with tirzepatide. A recent study has shown that tirzepatide, a medication commonly prescribed for type 2 diabetes and weight management, led to greater reductions in body weight, food consumption, and various appetite-related measures when [...]

Weight Loss Drugs: What You’re Not Hearing About GLP-1 And GIP Based Injectables For Weight Loss

Weight loss drugs: Real success is about taking control, gaining confidence, and achieving the energy to live life to the full, not simply shedding kilos.

Pharma Pulse 7/17/25: Inside the GLP-1 Strategy Driving Competitive Edge in Obesity Clinical Research; Eisai Highlights Long-Term Efficacy of Lenvima in Advanced HCC Treatment

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

Hengrui and Kailera report positive phase 3 results for dual GLP-1/GIP agonist in obesity treatment - Express Pharma

Hengrui Pharma and Kailera Therapeutics, have announced positive topline results from the Phase 3 clinical trial (HRS9531-301) of HRS9531, a once-weekly injectable dual GLP-1/GIP receptor agonist for adults with obesity or overweight. The randomised, double-blind, placebo-controlled study was conducted in China and included 567 participants. The trial met both its primary endpoints. Participants receiving HRS9531 (2 mg, 4 mg, and 6 mg) experienc…

Experts recommend healthy lifestyle changes alongside GLP-1 drug use – RamaOnHealthcare

GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything at all.But that's a false notion, experts say. Losing weight properly and keeping it off will require lifestyle changes that extend beyond a weekly GLP-1 injection."Many patients lose muscle mass in addition to [...]